![Yong-Gwan Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 14 413 $ au 30/06/2026
Yong-Gwan Kim currently works at JW SHINYAK Corp., as Chief Executive Officer & Director from 2022.
Mr. Kim also formerly worked at JW Life Science Corp., as Director & Head-Business Planning and JW PHARMACEUTICAL Corp., as Director from 2020 to 2021.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
JW SHINYAK CORP. 0,02 % | 02/01/2026 | 11 576 ( 0,02 % ) | 14 413 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| JW SHINYAK CORPORATION | Directeur Général | 23/12/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| JW PHARMACEUTICAL CORPORATION | Directeur/Membre du Conseil | 26/03/2021 |
| JW LIFESCIENCE CORPORATION | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
JW PHARMACEUTICAL Corp.
 JW PHARMACEUTICAL Corp. Pharmaceuticals: MajorHealth Technology Develops, produces and sells pharmaceutical products | Health Technology |
JW SHINYAK Corp.
 JW SHINYAK Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
JW Life Science Corp.
 JW Life Science Corp. Pharmaceuticals: MajorHealth Technology Manufactures intravenous fluids | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
